Garmin announces 2024 Garmin Health Awards finalists
Fourth annual awards program recognizes the world's most innovative solutions that successfully integrate Garmin wearable technology into health and wellness programs...
News
eVisit Acquires UPMC’s Inpatient Teleconsult Technology and Secures Investments from UPMC Enterprises and MedStar Health to Expand Innovative Partnerships and Capabilities
Organizations also join growing list of eVisit co-development and advisory collaborators, strengthening the industry-leading platform recognized as "Best in KLAS" for...
INVI MindHealth, Founded by Former Navy SEAL and Goldman Sachs Associate, Closes $1.5 Million Series Seed Round to Advance Digital Mental Health Solutions
DENVER, June 25, 2024 /PRNewswire/ -- INVI MindHealth, a pioneering mental health technology company, proudly announces the successful close of its...
PMD Device Solutions Increases Financial Target with 160% to 260m SEK by YE 2026
STOCKHOLM, SWEDEN / ACCESSWIRE / June 25, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions (PMDS) today announced it...
Strenge Spine Center Launches Cutting-Edge Spine Care Solutions
PADUCAH, KY / ACCESSWIRE / June 25, 2024 / Strenge Spine Center, a pioneering provider of advanced spine care, is...
Driver Technologies, Panthera Logistics, and All-Med Express Partner To Support Medical Delivery Drivers Across the United States
Over 100 pharmacies and over 2,500 delivery drivers will leverage the Driver AI copilot app NEW YORK, NY / ACCESSWIRE...
NervGen Pharma to Advance NVG-300 into Preclinical Proof-of-Concept Stage
New molecule demonstrates efficacy in a challenging SCI modelExpanding pipeline into new indications of ischemic stroke and ALSVancouver, British Columbia--(Newsfile...
Health Canada Issues Three Export Permits to Optimi to Supply Patients Under Australia’s Authorised Prescriber Scheme
The Company will ship 160 doses of MDMA and psilocybin to Australian psychiatrists for the treatment of patients with PTSD...
Prospective Trial Shows Impact of Home OCT Guided Wet AMD Patient Management
Remote monitoring reduces office visit and treatment burden in some patientsManassas, Virginia--(Newsfile Corp. - June 25, 2024) - Digital healthcare...
DirectTrust(R) Announces Speaker Lineup for 2024 Annual Conference: The Future of Trust in Health
Discussions to focus on constructively bridging the tension of usability, privacy, security, and identity WASHINGTON, DC / ACCESSWIRE / June...
Nasdaq Panel Grants NLS Pharmaceutics’ Request for Extension to Comply with Continued Listing Requirements
ZURICH, SWITZERLAND / ACCESSWIRE / June 25, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a leading Swiss...
Safety Shot Announces Strategic Partnership with Chip Quigley and Ari Freedman
The Executives Will Support the Company with Deep Expertise Across Entertainment, Development and Distribution JUPITER, FL, June 25, 2024 (GLOBE...
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.
First Commercial Agreement for DispersinB®WINNIPEG, Manitoba, June 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”...
Oragenics, Inc. Announces Pricing of Public Offering
SARASOTA, Fla., June 25, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal...
Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London
Established in 1932, the London Clinic is the UK’s Most Renowned Independent, Private Hospital Payment to Aclarion for Each Nociscan...
Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy
SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based...
Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers
The pooled analysis included data from 4 international clinical trials spanning an array of hard-to-treat indications including skin, head &...
Kannalife Secures Funding of $1.49 Million from The Michael J. Fox Foundation for Parkinson’s Research
Funding of $1.49 million USD to support the development of KLS-13019 targeting neuroinflammation and mitochondrial dysfunction Kannalife has developed a...
Industry Leader John Maraganore, Ph.D., Joins Cybrexa Therapeutics as Strategic Advisor
NEW HAVEN, Conn., June 25, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class...
Tevogen Bio Announces Publication of Positive Phase I Clinical Trial Results for TVGN 489 in Blood Advances
WARREN, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage...